Akèy › Sklerodèm › Texas › Dallas
Etid klinik pou Sklerodèm nan Dallas, TX
5 etid pou Sklerodèm ap chèche patisipan nan sit nan ak bò kote Dallas (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- UT Southwestern Simmons Cancer Center - RedBird, Dallas
- UT Southwestern/Simmons Cancer Center-Dallas, Dallas
A Phase 1/2 Study of NKX019 in Subjects With Immune-Mediated Diseases (Ntrust-2)
Ap rekriteFaz 1/2
- Nkarta Investigational Site, Dallas
AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.
Ap rekriteFaz 2
- Artiva Investigational Site Red Oak, Red Oak · 18 mi lwen
Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
- UT Southwestern Medical Center - Department of Dermatology, Dallas
Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)
Ap rekriteFaz 2
- aTyr Investigative Site, Dallas
Etid Sklerodèm nan lòt vil
- New York City, NY11 etid
- Chicago, IL10 etid
- Ann Arbor, MI10 etid
- Houston, TX9 etid
- Durham, NC7 etid
- Los Angeles, CA7 etid
- Boston, MA7 etid
- Baltimore, MD6 etid
- New Orleans, LA6 etid
- Philadelphia, PA6 etid
- Pittsburgh, PA5 etid
- Edison, NJ4 etid
Lòt etid nan Dallas
- Kansè nan tete55 etid
- Kansè Poumon ki pa ti selil52 etid
- Ensifizyans kadyak42 etid
- Kansè Metastatik42 etid
- Kansè (tout kalite)37 etid
- Kansè pwostat36 etid
- Kansè kolorektal33 etid
- Obèsite31 etid
- Kansè ovè28 etid
- Kansè poumon27 etid
- Kansè vejik27 etid
- Kansè Endomèt24 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.